286 related articles for article (PubMed ID: 17576094)
1. Hand coordination as a quantitative measure of motor abnormality and therapeutic response in Parkinson's disease.
Benice TS; Lou JS; Eaton R; Nutt J
Clin Neurophysiol; 2007 Aug; 118(8):1776-84. PubMed ID: 17576094
[TBL] [Abstract][Full Text] [Related]
2. Manual transport in Parkinson's disease.
Hejduková B; Hosseini N; Johnels B; Ingvarsson PE; Steg G; Olsson T
Mov Disord; 2003 May; 18(5):565-72. PubMed ID: 12722171
[TBL] [Abstract][Full Text] [Related]
3. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
[TBL] [Abstract][Full Text] [Related]
4. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
[TBL] [Abstract][Full Text] [Related]
5. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.
Lee WY; Yoon WT; Shin HY; Jeon SH; Rhee PL
Mov Disord; 2008 Sep; 23(12):1696-700. PubMed ID: 18649391
[TBL] [Abstract][Full Text] [Related]
7. Grip force abnormalities in de novo Parkinson's disease.
Fellows SJ; Noth J
Mov Disord; 2004 May; 19(5):560-5. PubMed ID: 15133821
[TBL] [Abstract][Full Text] [Related]
8. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
[TBL] [Abstract][Full Text] [Related]
9. The beneficial effects of subthalamic nucleus stimulation on manipulative finger force control in Parkinson's disease.
Nowak DA; Topka H; Tisch S; Hariz M; Limousin P; Rothwell JC
Exp Neurol; 2005 Jun; 193(2):427-36. PubMed ID: 15869945
[TBL] [Abstract][Full Text] [Related]
10. Parkinsonian action tremor: interference with object manipulation and lacking levodopa response.
Raethjen J; Pohle S; Govindan RB; Morsnowski A; Wenzelburger R; Deuschl G
Exp Neurol; 2005 Jul; 194(1):151-60. PubMed ID: 15899252
[TBL] [Abstract][Full Text] [Related]
11. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
Goberman AM
Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
[TBL] [Abstract][Full Text] [Related]
12. Levodopa-induced striatal activation in Parkinson's disease: a functional MRI study.
Kraft E; Loichinger W; Diepers M; Lule D; Schwarz J; Ludolph AC; Storch A
Parkinsonism Relat Disord; 2009 Sep; 15(8):558-63. PubMed ID: 19467909
[TBL] [Abstract][Full Text] [Related]
13. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
[TBL] [Abstract][Full Text] [Related]
14. Assessment of fine motor control in individuals with Parkinson's disease using force tracking with a secondary cognitive task.
Pradhan SD; Brewer BR; Carvell GE; Sparto PJ; Delitto A; Matsuoka Y
J Neurol Phys Ther; 2010 Mar; 34(1):32-40. PubMed ID: 20212366
[TBL] [Abstract][Full Text] [Related]
15. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
16. Effect of ropinirole on visuo-motor test in newly diagnosed Parkinson's disease patients.
Badarny S; Stern A; Susel Z; Honigman S; Hocherman S
Acta Neurol Scand; 2006 May; 113(5):294-300. PubMed ID: 16629764
[TBL] [Abstract][Full Text] [Related]
17. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
[TBL] [Abstract][Full Text] [Related]
18. [Study of associated clinical variables and phenomenology of hallucinations in Parkinson's].
Cubo E; González M; Aguilar A; Quintana S
Neurologia; 2006; 21(1):12-8. PubMed ID: 16525921
[TBL] [Abstract][Full Text] [Related]
19. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
Rodrigues JP; Walters SE; Stell R; Mastaglia FL; Thickbroom GW
Neurosci Lett; 2008 Dec; 448(1):29-32. PubMed ID: 18952149
[TBL] [Abstract][Full Text] [Related]
20. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
